1 / 1

Emicizumab(Hemlibra)

Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection

Reference price:

Manufacturer:

Pfizer Inc.

Formulation:

INJECTION

Validity period:

24 months

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Hemlibra(Emicizumab) Instructions:Uses,Dosage, Side Effects

HEMLIBRA is a bispecific monoclonal antibody used for prophylactic treatment in hemophilia A patients.

Introduction to HEMLIBRA

HEMLIBRA (emicizumab-kxwh) is a subcutaneous injection designed to prevent bleeding episodes in patients with hemophilia A, with or without factor VIII inhibitors. It works by bridging factor IXa and factor X to restore clotting function. Available in multiple dosage strengths, it offers flexible dosing regimens for long-term management.

Generic name

Emicizumab(Hemlibra)

English name

Emicizumab

Alternative Names

Hemlibra

Drug prices

Indications

HEMLIBRA is indicated for routine prophylaxis in adult and pediatric patients (newborn and older) with congenital hemophilia A (Factor VIII deficiency), regardless of inhibitor status.

Therapeutic Target

Bispecific monoclonal antibody targeting Factor IXa and Factor X to restore the function of missing activated Factor VIII (FVIIIa)

Active Ingredients

Emicizumab

Dosage form

INJECTION

specifications

30mg/1mL/box

Description

Dosage and Administration

1. Loading Dose: 3 mg/kg subcutaneously once weekly for the first 4 weeks.

2. Maintenance Dose: Choose one of the following regimens:

1.5 mg/kg once weekly, or

3 mg/kg once every two weeks, or

6 mg/kg once every four weeks.

3. Discontinue prophylactic bypassing agents one day prior to initiating HEMLIBRA.

4. Factor VIII prophylaxis may be continued during the first week of HEMLIBRA therapy.

CATEGORY NAVIGATION

How to...

Sunday, September 28th, 2025, 14:29

How to Purchase Emicizumab

Emicizumab is a bispecific antibody drug used for preventing bleeding in patients with hemophilia A. Due to its...

Friday, September 26th, 2025, 15:26

How to Use Emicizumab

Emicizumab is a bispecific monoclonal antibody used for the treatment of hemophilia A with inhibitors. It restores...

Thursday, September 18th, 2025, 17:33

How Effective is Emicizumab in Treatment?

As an innovative therapeutic agent, Emicizumab has demonstrated considerable value in the field of hemophilia A...

Thursday, September 18th, 2025, 15:47

Indications of Emicizumab

Emicizumab is a revolutionary humanized bispecific monoclonal antibody that mimics the function of coagulation...

Thursday, September 18th, 2025, 15:14

Recommended Dosage of Emicizumab

Emicizumab is a subcutaneous injection preparation indicated for routine prophylactic treatment in adult and...

Friday, September 5th, 2025, 13:49

Departments

Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology

Contact Medical Consultant

Global Drug Search

Clinical recruitment

overseas medical treatment

Remote consultation

Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.

Click to submit medical consultant

Mailbox:Info@Lucius.La

Welcome To Consult